535 related articles for article (PubMed ID: 26441370)
21. The Role of Macrolides in Chronic Rhinosinusitis (CRSsNP and CRSwNP).
Oakley GM; Harvey RJ; Lund VJ
Curr Allergy Asthma Rep; 2017 May; 17(5):30. PubMed ID: 28429305
[TBL] [Abstract][Full Text] [Related]
22. Clinical implications of the immunomodulatory effects of macrolides on sinusitis.
Majima Y
Am J Med; 2004 Nov; 117 Suppl 9A():20S-25S. PubMed ID: 15586560
[TBL] [Abstract][Full Text] [Related]
23. History of macrolide use in pediatrics.
Klein JO
Pediatr Infect Dis J; 1997 Apr; 16(4):427-31. PubMed ID: 9109154
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Chinese herbal medicine compared with a macrolide in the treatment of chronic rhinosinusitis without nasal polyps.
Jiang RS; Wu SH; Tsai CC; Li YH; Liang KL
Am J Rhinol Allergy; 2012; 26(4):293-7. PubMed ID: 22801017
[TBL] [Abstract][Full Text] [Related]
25. [LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
Shteinberg M; Schneer S; Lavon O; Adir Y
Harefuah; 2016 Sep; 155(9):567-571. PubMed ID: 28530085
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of macrolide responders in persistent post-surgical rhinosinusitis.
Oakley GM; Christensen JM; Sacks R; Earls P; Harvey RJ
Rhinology; 2018 Jun; 56(2):111-117. PubMed ID: 29476191
[TBL] [Abstract][Full Text] [Related]
27. [Clinical observation of Clarithromycin combined with nasal steroid treatment for chronic rhinosinusitis].
Liu J; Liu L; Lu X; Zhong G; Wan Y; Li Q; Feng Z; Li X; Hong Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 25(8):360-3. PubMed ID: 21761711
[TBL] [Abstract][Full Text] [Related]
28. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial.
Videler WJ; Badia L; Harvey RJ; Gane S; Georgalas C; van der Meulen FW; Menger DJ; Lehtonen MT; Toppila-Salmi SK; Vento SI; Hytönen M; Hellings PW; Kalogjera L; Lund VJ; Scadding G; Mullol J; Fokkens WJ
Allergy; 2011 Nov; 66(11):1457-68. PubMed ID: 21884529
[TBL] [Abstract][Full Text] [Related]
29. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis.
Wallwork B; Coman W; Mackay-Sim A; Greiff L; Cervin A
Laryngoscope; 2006 Feb; 116(2):189-93. PubMed ID: 16467702
[TBL] [Abstract][Full Text] [Related]
30. Nasopharyngeal flora and drug susceptibility in children with macrolide therapy.
Iino Y; Sasaki Y; Miyazawa T; Kodera K
Laryngoscope; 2003 Oct; 113(10):1780-5. PubMed ID: 14520106
[TBL] [Abstract][Full Text] [Related]
31. Clinical implications of the immunomodulatory effects of macrolides.
Tamaoki J; Kadota J; Takizawa H
Am J Med; 2004 Nov; 117 Suppl 9A():5S-11S. PubMed ID: 15586558
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors for identifying macrolide responder in treating chronic rhinosinusitis.
Seresirikachorn K; Kerr SJ; Aeumjaturapat S; Chusakul S; Kanjanaumporn J; Wongpiyabovorn J; Snidvongs K
Rhinology; 2021 Jun; 59(3):284-291. PubMed ID: 33821291
[TBL] [Abstract][Full Text] [Related]
33. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage.
Yamada T; Fujieda S; Mori S; Yamamoto H; Saito H
Am J Rhinol; 2000; 14(3):143-8. PubMed ID: 10887619
[TBL] [Abstract][Full Text] [Related]
34. Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model study.
Zeng M; Li ZY; Ma J; Cao PP; Wang H; Cui YH; Liu Z
BMC Immunol; 2015 Jun; 16():37. PubMed ID: 26047816
[TBL] [Abstract][Full Text] [Related]
35. Long-term low-dose macrolides for chronic rhinosinusitis in adults - a systematic review of the literature.
Lasso A; Masoudian P; Quinn JG; Cowan J; Labajian V; Bonaparte JP; Kilty S
Clin Otolaryngol; 2017 Jun; 42(3):637-650. PubMed ID: 27809411
[TBL] [Abstract][Full Text] [Related]
36. The macrolides: erythromycin, clarithromycin, and azithromycin.
Alvarez-Elcoro S; Enzler MJ
Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
[TBL] [Abstract][Full Text] [Related]
37. Macrolide antibiotic therapy in patients with cystic fibrosis.
Schöni MH
Swiss Med Wkly; 2003 May; 133(21-22):297-301. PubMed ID: 12861467
[TBL] [Abstract][Full Text] [Related]
38. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis.
Schultz MJ
J Antimicrob Chemother; 2004 Jul; 54(1):21-8. PubMed ID: 15190022
[TBL] [Abstract][Full Text] [Related]
39. Introducing a Novel Combination Therapy with Macrolides for the Treatment of Chronic Rhinosinusitis: A Randomized Controlled Trial.
Askari M; Khezri M; Zoghi G
Iran J Med Sci; 2022 Nov; 47(6):533-540. PubMed ID: 36380971
[TBL] [Abstract][Full Text] [Related]
40. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.
Shinkai M; Henke MO; Rubin BK
Pharmacol Ther; 2008 Mar; 117(3):393-405. PubMed ID: 18289694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
